Sepsis and septic shock kill fast, often before the pathogen is identified, and decades of drug trials have failed. This report maps the two pathogen-agnostic approaches now in play: extracorporeal devices that filter blood to remove inflammatory mediators or endotoxin, and host-directed drugs that modulate the immune response without targeting a specific bug.
Three pages from this report, open in full. The rest opens when you own it.
Eight parts, the same tabs you get when you own the report.
7 use cases
The technology recommended for each, with the alternatives.
+ 4 more
10 classes
Every class compared, with its patent trend and leading players.
+ 7 more
6 sectors
Mapped against the classes, with who sits in each.
Published November 2026 · © 2026 Berkeley FIT LLC. All rights reserved.
+ 3 more
54 companies
Searchable and filterable by sector, class and relevance.
+ 51 more
174 products
The products behind the companies, grouped by class.
+ 171 more
1,928 patents
Dominant and emerging holders for each mechanism of action.
+ 7 more
4 pathways
What each means for timelines and cost.
2 catalogs
Take the data with you.